Targeted Bleeding Management Reduces the Requirements for Blood Component Therapy in Lung Transplant Recipients

Use of POCCT in lung-transplant surgery is associated with significant reductions in blood product use and cost. There were no detectable changes in outcome aside from a small decrease in early postoperative bleeding.